Canadian Fabry AssociationCanadian Fabry Association

Be Rare. Be You.
Get your tattoo!

Buy Now

Thank you for wearing hope!

Buy Now

Sangamo Therapeutics Initiates Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Sangamo expects to complete Biological License Application (BLA) submission under accelerated approval pathway in second quarter of 2026

News

Elfabrio (pegunigalsidase alfa) approved by Health Canada!

Elfabrio (pegunigalsidase alfa)

News

Patient Experience & Care Survey

Your Experience Matters

Event

BC/YT Patient Empowerment Meeting

November 22, 2025

Event

WHO WE ARE

The CFA encourages and supports research into the causes, treatment and management of Fabry disease, but most importantly arranges for, coordinates and increases the facilities available for diagnosis, consultation and treatment of those suffering from Fabry disease.

GET INVOLVED

The CFA is a small group of patients and their families that have gathered together to support and assist others in the community across Canada. If you have Fabry, or know someone affected by the disease, we hope that you will consider getting involved.

LEARN MORE

We are committed to improving the lives of those who live with and are affected by Fabry disease in Canada.

Julia Alton Executive Director